Defective human T-cell leukaemia virus type 1 (HTLV-1) genomes: No evidence in serologically indeterminate German blood donors but new type detected in established cell lines

Citation
Va. Morozov et al., Defective human T-cell leukaemia virus type 1 (HTLV-1) genomes: No evidence in serologically indeterminate German blood donors but new type detected in established cell lines, J MED VIROL, 66(1), 2002, pp. 102-106
Citations number
23
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Microbiology
Journal title
JOURNAL OF MEDICAL VIROLOGY
ISSN journal
01466615 → ACNP
Volume
66
Issue
1
Year of publication
2002
Pages
102 - 106
Database
ISI
SICI code
0146-6615(200201)66:1<102:DHTLVT>2.0.ZU;2-S
Abstract
Individuals reactive in antibody screening tests (ELISA) and with one or mo re reactions to HTLV-1 proteins on Western blotting, but lacking the criter ia of a confirmed HTLV infection, are not exceptional in regions with a low prevalence of HTLV-1/-2 infections. PCR analysis of these indeterminate sa mples, using "diagnostic" pol and tax sets of primers, give negative result s. However, expression of HTLV-1 defective proviruses with internal deletio ns undetectable by PCR with diagnostic primers could have taken place. Seve n German HTLV-1 ELISA-reactive blood donors, who showed reactivity also in Western blots against several viral proteins, and twenty haemophiliacs, wer e examined by nested PCR and/or PCR/Southern hybridisation with primers des igned for detection of HTLV-1 defective proviruses. No HTLV-1-specific ampl ification products were obtained. However, HTLV-1 defective proviruses with large internal deletions were detected in four out of five cell lines esta blished from symptomatic HTLV-1 cases and two in HUT-102 cells. In two ampl icons, short inverted rRNA sequences between gag and env fragments of HTLV- 1 defective proviruses were revealed. These results do not exclude the pres ence of defective HTLV-1 proviruses in individuals with indeterminate serol ogy although this is unlikely. (C) 2002 Wiley-Liss, Inc.